Conference on Retrovirus and Opportunistic Infections (CROI 2024), Denver, Colorado, USA, 3-6 March 2024.

Poster presentations:

• Novel Biomarkers as Determinants of HBsAg Loss in Persons with HIV/HBV on Tenofovir  presented by Lorin Begré on behalf of the EuroSIDA Study Group. POSTER  

IWHOD 2024, Vilamoura, Portugal, 21-23 March 2024

Poster presentations:

• Trends in AIDS-defining illnesses among people living with HIV in Europe: results from the EuroSIDA study (2003-2022) presented by Wendy Bannister on behalf of the EuroSIDA Study Group. POSTER

ECCMID 2024, Barcelona, Spain, 27-30 April 2024

Poster presentations:

• Trends in AIDS-defining illnesses among people living with HIV in Europe: results from the EuroSIDA study (2003-2022) presented by Wendy Bannister on behalf of the EuroSIDA Study Group. POSTER

The 25th International AIDS conference (IAS) 22 - 26 July  2024.

Oral presentation:

• Detailed modeling of viremia exposure does not independently predict cardiovascular diseases in people with HIV, presented by Olof Elvstam on behalf of the RESPOND Study Group.PRESENTATION
•  

Australasian HIV & AIDS conference (ASHM), Sydney, Australia, 16-18 September 2024.

Oral presentation:

Risk of cancer in people with HIV with poor immune recovery despite sustained virological suppression for more than two years on effective antiretroviral treatment, presented by Win Min Han on behalf of the RESPOND Study Group.PRESENTATION 

HIV Drug Therapy Glasgow 2024, Glasgow, Great Britain, 10-13 November 2024.

Poster presentation: 
Outcomes after the most common cancers in people with HIV  presented by Alisa Timiryasova on behalf of the RESPOND  and D:A:D  study groups.POSTER

Poster presentation:
Mortality using raltegravir versus other integrase inhibitors in people with HIV in Europe and Australia  presented by Erich Tusch on behalf of the RESPOND study group.POSTER

Poster presentation:
Prevalence of HIV drug resistance in people newly diagnosed with HIV who have used pre-exposure prophylaxis in Europe: the PrEPaRE study,  presented by Valentina Cambiano on behalf of the RESPOND study group.POSTER

Poster presentation:

Changes in the ART coverage and viral suppression from 2020 to 2022 in Kyiv, Ukraine presented by Olga Fursa on behalf of the CARE study group.